TMOD-14. CREATION OF A GENETICALLY ENGINEERED MOUSE MODEL OF ANAPLASTIC ASTROCYTOMA DRIVEN BY THE IDH1-R132H ONCOGENE
Diana D. Shi(Harvard University), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Michael M. Levitt(University of North Texas), Sabina Signoretti(Brigham and Women's Hospital), Rebecca B. Jennings(IHS Markit (United States)), Adam Wang(Harvard University), Quang‐Dé Nguyen(Dana-Farber Cancer Institute), Januka Khanal(Brigham and Women's Hospital), Dennis M. Bonal(Dana-Farber Cancer Institute), Kalil G. Abdullah(University of Pittsburgh), William G. Kaelin(Broad Institute), Keith L. Ligon(Brigham and Women's Hospital), Wenhua Gao(Brigham and Women's Hospital), Daniel P. Cahill(Harvard University)
Cited by 1
Related Papers
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O <sub>2</sub> Sensing
|Science|2001|4.7k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
|Nature Cell Biology|2000|1.6k